: FDA authorizes Pfizer-BioNTech booster for young kids with compromised immune systems


The U.S. Food and Drug Administration late Friday authorized Pfizer Inc. PFE and BioNTech SE BNTX COVID-19 bivalent vaccine for immunocompromised children. The shot, which would be a fourth dose in most cases, can be given to children older than 6 months through 4 years of age who have previously received the vaccine’s three doses, the FDA said. The extra dose would be administered at least 1 month following the most recent dose. The FDA earlier this month authorized the additional booster shot for people over the age of 65 and people with compromised immune systems.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleMarket Extra: First Republic seen drawing bids from JPMorgan and PNC amid report of ‘imminent’ FDIC seizure
Next articleChicago regional business-activity index brightening in April


Please enter your comment!
Please enter your name here